Literature DB >> 31413006

Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI.

E Aliotta1, H Nourzadeh2, P P Batchala3, D Schiff4, M B Lopes5, J T Druzgal3, S Mukherjee3, S H Patel3.   

Abstract

BACKGROUND AND
PURPOSE: Image-based classification of lower-grade glioma molecular subtypes has substantial prognostic value. Diffusion tensor imaging has shown promise in lower-grade glioma subtyping but currently requires lengthy, nonstandard acquisitions. Our goal was to investigate lower-grade glioma classification using a machine learning technique that estimates fractional anisotropy from accelerated diffusion MR imaging scans containing only 3 diffusion-encoding directions.
MATERIALS AND METHODS: Patients with lower-grade gliomas (n = 41) (World Health Organization grades II and III) with known isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status were imaged preoperatively with DTI. Whole-tumor volumes were autodelineated using conventional anatomic MR imaging sequences. In addition to conventional ADC and fractional anisotropy reconstructions, fractional anisotropy estimates were computed from 3-direction DTI subsets using DiffNet, a neural network that directly computes fractional anisotropy from raw DTI data. Differences in whole-tumor ADC, fractional anisotropy, and estimated fractional anisotropy were assessed between IDH-wild-type and IDH-mutant lower-grade gliomas with and without 1p/19q codeletion. Multivariate classification models were developed using whole-tumor histogram and texture features from ADC, ADC + fractional anisotropy, and ADC + estimated fractional anisotropy to identify the added value provided by fractional anisotropy and estimated fractional anisotropy.
RESULTS: ADC (P = .008), fractional anisotropy (P < .001), and estimated fractional anisotropy (P < .001) significantly differed between IDH-wild-type and IDH-mutant lower-grade gliomas. ADC (P < .001) significantly differed between IDH-mutant gliomas with and without codeletion. ADC-only multivariate classification predicted IDH mutation status with an area under the curve of 0.81 and codeletion status with an area under the curve of 0.83. Performance improved to area under the curve = 0.90/0.94 for the ADC + fractional anisotropy classification and to area under the curve = 0.89/0.89 for the ADC + estimated fractional anisotropy classification.
CONCLUSIONS: Fractional anisotropy estimates made from accelerated 3-direction DTI scans add value in classifying lower-grade glioma molecular status.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31413006      PMCID: PMC7048441          DOI: 10.3174/ajnr.A6162

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  36 in total

1.  Robust brain extraction across datasets and comparison with publicly available methods.

Authors:  Juan Eugenio Iglesias; Cheng-Yi Liu; Paul M Thompson; Zhuowen Tu
Journal:  IEEE Trans Med Imaging       Date:  2011-09       Impact factor: 10.048

2.  T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.

Authors:  Sohil H Patel; Laila M Poisson; Daniel J Brat; Yueren Zhou; Lee Cooper; Matija Snuderl; Cheddhi Thomas; Ana M Franceschi; Brent Griffith; Adam E Flanders; John G Golfinos; Andrew S Chi; Rajan Jain
Journal:  Clin Cancer Res       Date:  2017-07-27       Impact factor: 12.531

3.  Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.

Authors:  Rachel L Delfanti; David E Piccioni; Jason Handwerker; Naeim Bahrami; AnithaPriya Krishnan; Roshan Karunamuni; Jona A Hattangadi-Gluth; Tyler M Seibert; Ashwin Srikant; Karra A Jones; Vivian S Snyder; Anders M Dale; Nathan S White; Carrie R McDonald; Nikdokht Farid
Journal:  J Neurooncol       Date:  2017-09-04       Impact factor: 4.130

4.  A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.

Authors:  M Vallières; C R Freeman; S R Skamene; I El Naqa
Journal:  Phys Med Biol       Date:  2015-06-29       Impact factor: 3.609

5.  Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Authors:  S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

6.  Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.

Authors:  Chong Hyun Suh; Ho Sung Kim; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2018-07-12       Impact factor: 5.315

7.  Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation.

Authors:  Konstantinos Kamnitsas; Christian Ledig; Virginia F J Newcombe; Joanna P Simpson; Andrew D Kane; David K Menon; Daniel Rueckert; Ben Glocker
Journal:  Med Image Anal       Date:  2016-10-29       Impact factor: 8.545

8.  Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing.

Authors:  Jörg Felsberg; Marietta Wolter; Heike Seul; Britta Friedensdorf; Matthias Göppert; Michael C Sabel; Guido Reifenberger
Journal:  Acta Neuropathol       Date:  2010-02-04       Impact factor: 15.887

Review 9.  False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review.

Authors:  Anastasia Chalkidou; Michael J O'Doherty; Paul K Marsden
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

10.  Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging.

Authors:  Seunghyun Lee; Seung Hong Choi; Inseon Ryoo; Tae Jin Yoon; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Ji-Hoon Kim; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  J Neurooncol       Date:  2014-09-10       Impact factor: 4.506

View more
  11 in total

1.  Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.

Authors:  P Darvishi; P P Batchala; J T Patrie; L M Poisson; M-B Lopes; R Jain; C E Fadul; D Schiff; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-23       Impact factor: 3.825

2.  Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.

Authors:  Mingxiao Li; Xiaohui Ren; Xuzhu Chen; Jincheng Wang; Shaoping Shen; Haihui Jiang; Chuanwei Yang; Xuzhe Zhao; Qinghui Zhu; Yong Cui; Song Lin
Journal:  Eur Radiol       Date:  2022-01-25       Impact factor: 5.315

3.  Prediction of Lower Grade Insular Glioma Molecular Pathology Using Diffusion Tensor Imaging Metric-Based Histogram Parameters.

Authors:  Zhenxing Huang; Changyu Lu; Gen Li; Zhenye Li; Shengjun Sun; Yazhuo Zhang; Zonggang Hou; Jian Xie
Journal:  Front Oncol       Date:  2021-03-10       Impact factor: 6.244

4.  MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma.

Authors:  David A Joyner; John Garrett; Prem P Batchala; Bharath Rama; Joshua R Ravicz; James T Patrie; Maria-B Lopes; Camilo E Fadul; David Schiff; Rajan Jain; Sohil H Patel
Journal:  Neuroradiology       Date:  2022-08-12       Impact factor: 2.995

5.  Prediction of lower-grade glioma molecular subtypes using deep learning.

Authors:  Yutaka Matsui; Takashi Maruyama; Masayuki Nitta; Taiichi Saito; Shunsuke Tsuzuki; Manabu Tamura; Kaori Kusuda; Yasukazu Fukuya; Hidetsugu Asano; Takakazu Kawamata; Ken Masamune; Yoshihiro Muragaki
Journal:  J Neurooncol       Date:  2019-12-21       Impact factor: 4.130

Review 6.  MRI biomarkers in neuro-oncology.

Authors:  Marion Smits
Journal:  Nat Rev Neurol       Date:  2021-06-20       Impact factor: 42.937

Review 7.  Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.

Authors:  Francesco Sanvito; Antonella Castellano; Andrea Falini
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

8.  FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling.

Authors:  Yichang Wang; Alafate Wahafu; Wei Wu; Jianyang Xiang; Longwei Huo; Xudong Ma; Ning Wang; Hao Liu; Xiaobin Bai; Dongze Xu; Wanfu Xie; Maode Wang; Jia Wang
Journal:  J Cell Mol Med       Date:  2021-04-09       Impact factor: 5.310

9.  RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas.

Authors:  Xu Zhao; Yuzhu Wang; Jing Li; Fengyi Qu; Xing Fu; Siqi Liu; Xuan Wang; Yuchen Xie; Xiaozhi Zhang
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

Review 10.  Alternations and Applications of the Structural and Functional Connectome in Gliomas: A Mini-Review.

Authors:  Ziyan Chen; Ningrong Ye; Chubei Teng; Xuejun Li
Journal:  Front Neurosci       Date:  2022-04-11       Impact factor: 5.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.